Author: Ahmad Khosravi; Reza Chaman; Marzieh Rohani-Rasaf; Fariba Zare; Shiva Mehravaran; Mohammad Hassan Emamian
Title: The basic reproduction number and prediction of the epidemic size of the novel coronavirus (COVID-19) in Shahroud, Iran Document date: 2020_4_8
ID: 36fbcobw_25
Snippet: The trend of R 0 over time provides a measure of the effectiveness of control and prevention strategies in the community, and to control an epidemic, the goal is to reduce and keep R 0 below the value of 1 [13] . In the present study, the estimated R 0 of 2.7 (95% CI, 2.1 to 3.4) during the early stage of the epidemic is in line with previous estimates [10, [14] [15] [16] . However, higher estimates of R 0 have been reported in larger populations.....
Document: The trend of R 0 over time provides a measure of the effectiveness of control and prevention strategies in the community, and to control an epidemic, the goal is to reduce and keep R 0 below the value of 1 [13] . In the present study, the estimated R 0 of 2.7 (95% CI, 2.1 to 3.4) during the early stage of the epidemic is in line with previous estimates [10, [14] [15] [16] . However, higher estimates of R 0 have been reported in larger populations [17, 18] . For precise estimation of R 0 , certain conditions must be met which include the precise detection of cases in the early stages of the epidemic, restricting the calculation to a small timeframe [12] , and choosing the appropriate estimation method [13, 19] . For precise detection of cases, all suspected cases (according to the screening protocol) and cases who have had close contact with confirmed cases should undergo viral nucleic acid testing. In Shahroud, there were 1055 suspected cases, and 405 of them tested positive. However, in the early stages of the epidemic in Iran, there was limited capacity for testing, and the calculated R 0 may be an underestimation.
Search related documents:
Co phrase search for related documents- limited capacity and positive test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- nucleic acid testing and positive test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- nucleic acid testing and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9
- nucleic acid testing and prevention control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
- nucleic acid testing and screening protocol: 1, 2
- nucleic acid testing and testing limited capacity: 1, 2
- nucleic acid testing and time provide: 1, 2, 3
- nucleic acid testing and viral nucleic acid testing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44
- positive test and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- positive test and prevention control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- positive test and prevention control strategy: 1, 2
- positive test and previous estimate: 1, 2
- positive test and screening protocol: 1, 2, 3, 4, 5, 6
- positive test and suspect case: 1, 2
- positive test and testing limited capacity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- positive test and time provide: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- positive test and viral nucleic acid testing: 1, 2, 3, 4
- precise detection and present study: 1, 2, 3, 4, 5
- precise detection and prevention control: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date